πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9072716

Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cell

The United States of America, as represented by the Secretary Department of Health by Human Servies Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9074185

Adoptive cell therapy with young T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9074195

Nanoparticle entrapment of materials

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9068003

Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease co

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9068165

Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066948

Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066965

Purified limonin glucoside for prevention and treatment of chronic diseases

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056891

Synthetic peptide inhibitors of Wnt pathway

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056068

Vaccine and methods of use against Strongyloide stercoralis infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056907

Human domain antibodies against components of the human insulin-like growth factor (IGF) s

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9050285

Recombinant bacterium capable of eliciting an immune response against Streptococcus pneum

The United States of America National Institutes of Health (NH), U.S. Dept. of Health and Human Services (DHHS) Β· Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9050300

Surgical applications for BMP binding protein

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9046520

Serologic correlates of protection against Bacillis anthracis infection

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044451

Use of delta tocopherol for the treatment of lysosomal storage disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044457

Anti-DR4 agonist antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044509

Inhibition of HIV infection through chemoprophylaxis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9040233

Methods for detecting a Mycobacterium tuberculosis infection

The United States of America, DBA The Department of Veteran Affairs Β· Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9034343

Attenuated human parainfluenza virus, methods and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9028887

Method improve spatial memory via pterostilbene administration

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9029344

Linked purine pterin HPPK inhibitors useful as antibacterial agents

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9018371

Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositio

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9017982

Non-wild-type organophosphorus acid anhydrolases for enzymatic decontamination

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9018227

Nicotinic acetylcholine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9012618

Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity whi

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted